The Omnicell Blog
The pharmacy world is changing fast. The emergence of pharmacy intelligence, predictive analytics, and increasing demand for a complete end-to-end solution means healthcare leaders must innovate to meet both new medication management challenges (COVID-19) and old (diversion, patient safety, and rising costs).
The Omnicell Blog is the leading source for pharmacy information on emerging trends, successful best practices, and ideas and insights to help pharmacies digitally transform to lower cost and improve patient safety.
Ensuring Medication Safety Through Automation Designed to Support ISMP Best Practices
The Institute for Safe Medication Practices has established best practice guidelines for specific medication safety issues that continue to cause fatal and harmful errors in patients. The goal is to support the safety of the medication distribution process while making required drugs readily accessible in a variety of patient care areas.
How Digital Transformation in Pharmacy Is Driving Culturally Competent Care
Pharmacists are consistently ranked among the top-most trusted professions. But under-utilization of the pharmacist is resulting in a significant lost opportunity for clinical excellence and patient satisfaction. The digital transformation of healthcare is the opportunity for pharmacy to move back to the center of culturally competent patient care.
Strong Pharmacy-Finance Partnerships Key to Navigating 340B Program Challenges
For nearly 30 years, the 340B Drug Pricing Program has provided vital financial support to nonprofit hospitals and is now considered an important element of hospital finance in many communities. But a variety of industry and regulatory pressures are making the program increasingly complex. What was once easily managed within the hospital pharmacy department now frequently requires a cross-functional approach involving the hospital finance department, hospital operations and healthcare providers.
Why 340B Covered Entities Need Swift Action on Contract Pharmacies
There have already been numerous actions in the various legal cases surrounding the 340B drug discount program, including motions to dismiss, requests to intervene, requests for a stay, granting of a stay, joint status reports, friend of the court filings and requests for additional briefings, to name a few. The pharmaceutical industry has been the winner so far on procedural issues.
Why You Need Pharmacy Automation in Your OR
The OR is one of the most dynamic environments across any health system. In this space, where patient acuity is high and the process for medication use is highly regulated, anesthesia providers must remain single-mindedly focused on patient care – not administrative tasks. At the same time, pharmacy needs to maintain a strong chain of custody for controlled substances.
The Potential Value Industry Leaders See in the Autonomous Pharmacy
The Autonomous Pharmacy Advisory Board has coalesced around the clear vision of a fully autonomous pharmacy. Recent AJHP commentary details a framework that identifies five levels of increasing technological capability and work process improvement spanning nine pharmacy work processes. The ultimate goal is near error-free medication management that optimizes the benefits and minimizes the harm and costs of medication use.
Why Community Pharmacy Is the Future of Patient Care
Local pharmacists have always strived to be more than medication dispensers. With the onset of the COVID-19 pandemic, pharmacists now have the opportunity to practice at the top of their license, offering comforting support and vital healthcare expertise right next door.
Best Practices for Building a Successful Autonomous Pharmacy Business Case
The Autonomous Pharmacy can help to solve clinical and operational challenges. But gaining organizational support and approval for the technology investment can be complex and challenging to navigate; solid Value Justification can demonstrate the transformational value for health system leadership.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.